Back to results
US 2004/0006117 A1Published application
Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactions
AssigneeSchering Corporation
InventorsThorsten Blume, Wolf-Dietrich Doecke, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Moenning, Bernd Elger, Herbert Schneider
Life of this patent
Estimating the term…
Abstract
The invention describes the use of microglia inhibitors for the production of pharmaceutical agents that inhibit immune reactions that are mediated by monocytes, macrophages and T cells, and their use for treating T-cell-mediated immunological diseases and non-T-cell-mediated inflammation reactions.
Claims8
Use of a microglia inhibitor for the production of a pharmaceutical agent for treating immune reactions that are mediated by monocytes, macrophages or T cells.
Dependencies are inferred from the claim text.